Handelsbanken Fonder AB raised its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 0.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,700 shares of the company’s stock after purchasing an additional 200 shares during the period. Handelsbanken Fonder AB’s holdings in Doximity were worth $1,586,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its holdings in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock worth $31,000 after acquiring an additional 235 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock worth $93,000 after acquiring an additional 296 shares during the period. MetLife Investment Management LLC raised its holdings in Doximity by 0.6% in the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock valued at $2,835,000 after buying an additional 363 shares during the period. State of Alaska Department of Revenue raised its holdings in Doximity by 2.6% in the fourth quarter. State of Alaska Department of Revenue now owns 14,610 shares of the company’s stock valued at $780,000 after buying an additional 370 shares during the period. Finally, First Horizon Advisors Inc. raised its holdings in Doximity by 22.5% in the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock valued at $91,000 after buying an additional 384 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several research firms recently commented on DOCS. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a report on Friday, February 7th. Truist Financial raised their price target on shares of Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a report on Thursday, November 14th. Needham & Company LLC raised their price target on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a report on Friday, February 7th. The Goldman Sachs Group raised their price target on shares of Doximity from $58.00 to $80.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Finally, JPMorgan Chase & Co. raised their price target on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a report on Thursday, November 21st. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $64.22.
Doximity Trading Up 1.7 %
DOCS stock opened at $72.91 on Thursday. The company has a market capitalization of $13.61 billion, a P/E ratio of 72.91, a PEG ratio of 4.10 and a beta of 1.39. The firm has a 50 day simple moving average of $61.37 and a 200-day simple moving average of $50.13. Doximity, Inc. has a twelve month low of $22.96 and a twelve month high of $85.21.
Insiders Place Their Bets
In other Doximity news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the transaction, the director now owns 6,360 shares of the company’s stock, valued at $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. 37.40% of the stock is currently owned by corporate insiders.
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
See Also
- Five stocks we like better than Doximity
- Investing in Travel Stocks Benefits
- Buffett’s on the Sidelines – Should You Follow?
- Technology Stocks Explained: Here’s What to Know About Tech
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- What is Insider Trading? What You Can Learn from Insider Trading
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCS – Free Report).
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.